Skip to main content

Health In Tech, Inc.

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 13, 2026

HIT$0.56-3.3%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 10 previous paragraphs and 13 current paragraphs.

8 unchanged; 1 reworded; 4 added; 1 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 3 previous and 3 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (4)

Current report

Our ability to accurately perform underwriting procedures

Current report

Our growth is significantly dependent on our ability to accurately perform underwriting procedures and maintain strong relationships with brokers, TPAs, carriers, MGUs and other third-party agents who utilize our platforms. A failure to conduct precise underwriting actuarial reviews and adjustments to our underwriting tools could result in increased costs and pricing for health plans.

Current report

While our agreements with brokers, TPAs, carriers, MGUs and other third-party agents generally do not necessitate our payment of fees exceeding estimated insurance costs, nor do we have agreements that require indemnification of any carrier, such a failure could cause reputational harm to our eDIYBS platform. This could lead to increased premiums for plans accessed through our platform, potentially affecting our financial standing and market competitiveness.

Current report

On June 15, 2026, we issued 95,238 RSAs outside of our equity incentive plans to a consulting firm in exchange for the firm’s consulting services. The Company issued such restricted stock in reliance upon the exemption from the securities registration requirements of the Securities Act of 1933, as amended, afforded by the provisions of Section 4(a)(2) thereof and the rules and regulations promulgated thereunder.
Removed paragraphs (1)

Previous report

On March 25, 2026, we entered into a securities purchase agreement with the accredited investors named in the signature pages thereto for a private investment in public equity financing (the “PIPE”), which closed on March 27, 2026, resulting in gross proceeds to us of $7.0 million, before deducting placement agent fees and offering expenses. In connection with the closing of the PIPE, and in reliance upon the exemption from registration requirements of Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, we issued an aggregate of 5,600,000 shares of Class A Common Stock at a purchase price of $1.25 per share. We received net proceeds of $6,381,000 after deducting placement agent fees and escrow agent fees of $619,000, and intend to use the net proceeds from the PIPE for sales distribution expansion, technology development, and general corporate purposes.
Reworded paragraphs (1)

Previous wording

Risk factors that may affect our business and financial results are discussed within Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on March 25, 2026, and our subsequent filings with the SEC.

Current wording

Risk factors that may affect our business and financial results are discussed within Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on March 25, 2026, and our subsequent filings with the SEC. In addition to those in our prior filings, the following is an additional risk factor to consider: